Infectious agents in the pathogenesis of primary biliary cirrhosis

Disease Markers

Volumn 29, Issue 6, 2010, Pages 277-286

  Ortega Hernandez, Oscar Danilo ^a   Levin, Nancy Agmon ^a,b   Altman, Arie ^a,b   Shoenfeld, Yehuda ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Autoimmunity; Infectious agents; Molecular mimicry; Primary biliary cirrhosis; Tolerance

Indexed keywords

2 OXOISOVALERATE DEHYDROGENASE (LIPOAMIDE); MITOCHONDRION ANTIBODY; PYRUVATE DEHYDROGENASE COMPLEX;

ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CROSS REACTION; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HELICOBACTER PYLORI; HEPATOBILIARY SYSTEM; HUMAN; LACTOBACILLUS; LACTOBACILLUS DELBRUECKII; MOLECULAR MIMICRY; MOUSE MAMMARY TUMOR ONCOVIRUS; MYCOBACTERIUM; MYCOBACTERIUM GORDONAE; NONHUMAN; NOSPHINGOBIUM AROMATICIVORANS; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; T LYMPHOCYTE; YERSINIA ENTEROCOLITICA;

ESCHERICHIA COLI; NEGIBACTERIA;

EID: 79951592242     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.3233/DMA-2010-0771     Document Type: Article

References (77)

1. M.M. Kapla (Pubitemid 41345948)
2. J. Underhill, P. Donaldson, G. Bray, D. Doherty, B. Portmann and R. Williams, Susceptibility to primary biliary cirrhosis is associated with the HLADR8DQB1*0402 haplotype, Hepatology 16 (1992), 1404-1408.
3. M.E. Gershwin, C. Selmi, H.J. Worman, E.B. Gold, M. Watnik, J. Utts et al., Risk factors and comorbidities in primary biliary cirrhosis: a controlled interviewbased study of 1032 patients, Hepatology 42 (2005), 1194-1202. (Pubitemid 43112687)
4. X.S. He, A.A. Ansari, W.M. Ridgway, R.L. Coppel and M.E. Gershwin, New insights to the immunopathology of autoimmune responses in primary biliary cirrhosis, Cell Immunol 239 (2006), 1-13. (Pubitemid 43927662)
5. S. Braun, C. Berg, S. Buck, M. Gregor and R. Klein, Catalytic domain of PDCE2 contains epitopes recognized by antimitochondrial antibodies in primary biliary cirrhosis, World J Gastroenterol 16 (2010), 973-981.
6. S.J. Yeaman, S.P. Fussey, D.J. Danner, O.F. James, D.J. Mutimer and M.F. Bassendine, Primary biliary cirrhosis: identification of two major M2 mitochondrial autoantigens, Lancet 1 (1988), 1067-1070.
7. L. Vilagut, A. Parés, O. Viñas, J. Vila, M.T. Jiménez de Anta and J. Rodés, Antibodies to mycobacterial 65 kD heat shock protein crossreact with the main mitochondrial antigens in patients with primary biliary cirrhosis, Eur J Clin Invest 27 (1997), 667-672. (Pubitemid 27368297)
8. C. Selmi andM.E. Gershwin, Apocalypsal versus apocryphal: the role of retroviruses in primary biliary cirrhosis, Am J Gastroenterol 99 (2004), 2356-2358. (Pubitemid 40039365)
9. C. Selmi and M.E. Gershwin, Bacteria and human autoimmunity: the case of primary biliary cirrhosis, Curr Opin Rheumatol 16 (2004), 406-410. (Pubitemid 38803142)
10. N. Agmon-Levin, B.S. Katz and Y. Shoenfeld, Infection and primary biliary cirrhosis, IsrMed Assoc J 11 (2009), 112-115.
11. D.P. Bogdanos and D. Vergani, Bacteria and primary biliary cirrhosis, Clin Rev Allergy Immunol 36 (2009), 30-39.
12. A.K. Burroughs, I.J. Rosenstein, O. Epstein, J.M. HamiltonMiller, W. Brumfitt and S. Sherlock, Bacteriuria and primary biliary cirrhosis, Gut 25 (1984),133-137. (Pubitemid 14131405)
13. D. TaylorRobinson, A.W. Sharif, N.S. Dahanjal and S.D. TaylorRobinson, Chlamydia pneumoniae infection is an unlikely cause of primary biliary cirrhosis, J Hepatol 42 (2005), 778-780.
14. D.P. Bogdanos, H. Baum, A. Grasso, M. Okamoto, P. Butler, Y. Ma et al., Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis, J Hepatol 40 (2004), 31-39. (Pubitemid 38064710)
15. J.P. Mohammed and J. Mattner, Autoimmune disease triggered by infection with alphaproteobacteria, Expert Rev Clin Immunol 5 (2009), 369-379.
16. V. Barak, C. Selmi, M. Schlesinger, M. Blank, N. AgmonLevin, I. Kalickman et al., Serum inflammatory cytokines, complement components, and soluble interleukin 2 receptor in primary biliary cirrhosis, J Autoimmun 33 (2009), 178-182.
17. M.E. Gershwin, A.A. Ansari, I.R. Mackay, Y. Nakanuma, A. Nishio, M.J. Rowley et al., Primary biliary cirrhosis: an orchestrated immune response against epithelial cells, Immunol Rev 174 (2000), 210-225. (Pubitemid 30201390)
18. J.V. Metcalf, H.C. Mitchison, J.M. Palmar, D.E. Jones, M.E. Basssendine and O.F. James, Natural history of early primary biliary cirrhosis, Lancet 348 (1996), 1399-1402. (Pubitemid 26395233)
19. M.E.Gershwin and I.R.Mackay, The causes of primary biliary cirrhosis:convenient and inconvenient truths, Hepatology 47 (2008), 737-745. (Pubitemid 351280742)
20. Y. Ueno, Y.M. Ambrosini, Y. Moritoki, W.M. Ridgway and M.E. Gershwin, Murine models of autoimmune cholangitis, Curr Opin Gastroenterol 26 (2010), 274-479.
21. J.Van deWater, H. Ishibashi, R.L. Coppel andM.E.Gershwin, Molecular mimicry and primary biliary cirrhosis: premises not promises, Hepatology 33 (2001), 771-775. (Pubitemid 32246623)
22. H.Kita, S.Matsumura, X.S.He,A.A.Ansari, Z.X. Lian, J.Van de Water et al., Quantitative and functional analysis of PDC E2 specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis, J Clin Invest 109 (2002), 1231-1240. (Pubitemid 34496601)
23. D.E.J. Jones, A. Robe, J. Palmer and J.A. Kirby, Adoptive transfer of selfPDCreactive Tcells into näive mice induces portal tract and bile duct changes characteristic of primary biliary cirrhosis (PBC), J Hepatol 44(Suppl 2) (2006), S10.
24. H. Tanimoto, S. Shimoda, M. Nakamura, H. Ishibashi, A. Kawano, T. Kamihira et al., Promiscuous T cells selected by Escherichia coli: OGDCE2 in primary biliary cirrhosis, J Autoimmun 20 (2003), 255-263. (Pubitemid 36561491)
25. N.AgmonLevin, M. Blank, Z. Paz and Y. Shoenfeld, Molecularmimicry in systemic lupus erythematosus, Lupus 18 (2009), 1181-1185.
26. R. Klein, M. Wiebel, S. Engelhart and P.A. Berg, Sera from patients with tuberculosis recognize theM2aepitope (E2 subunit of pyruvate dehydrogenase complex) specific for primary biliary cirrhosis, Clin Exp Immunol 92 (1993), 308-316. (Pubitemid 23151043)
27. P.V. Lehmann, T. Forsthuber, A. Miller and E.E. Sercarz, Spreading of Tcell autoimmunity for cryptic determinants of an autoantigen, Nature 358 (1992), 155-157.
28. P.A. Berg, Autoimmunity in primary biliary cirrhosis: An alternative viewat initiation and function of antimitochondrial autoantibodies, Hepatol 50 (2009), 827-828.
29. Y. Ichiki, S. Shimoda, H. Ishibashi and M.E. Gershwin, Is primary biliary cirrhosis a model autoimmune disease, Autoimmun Rev 3 (2004), 331-336. (Pubitemid 38887629)
30. M.M. Kaplan, Novosphingobium aromaticivorans: a potential initiator of primary biliary cirrhosis, Am J Gastroenterol 99 (2004), 2147-2149. (Pubitemid 39524705)
31. C. Selmi, D.L. Balkwill, P. Invernizzi, A.A. Ansari, R.L. Coppel, M. Podda et al., Patients with primary biliary cirrhosis react against a ubiquitous xenobioticmetabolizing bacterium, Hepatology 38 (2003), 1250-1257. (Pubitemid 37314834)
32. S. Olafsson, H. Gudjonsson, C. Selmic, K. Amano, P. Invernizzi, M. Podda et al., Antimitochondrial antibodies and reactivity to N. aromaticivorans proteins in Icelandic patients with primary biliary cirrhosis and their relatives, Am J Gastroenterol 99 (2004), 2143-2146. (Pubitemid 39524704)
33. D.R. Triger, Primary biliary cirrhosis: An epidemiological study, Br Med J 281 (1980), 772-775. (Pubitemid 10048546)
34. M.I. Pince, A. Chetwynd, P. Diggle, M. Jarner, J.V. Metcalf and O.F. James, The geographical distribution of primary biliary cirrhosis in welldefined cohort, Hepatology 34 (2001), 1083-1088. (Pubitemid 33096579)
35. J. Mattner, P.B. Savage, P. Leung, S.S. Oertelt, V. Wang, O. Trivedi et al., Liver autoimmunity triggered by microbial activation of natural killer T cells, Cell Host Microbe 3 (2008), 304-315. (Pubitemid 351637431)
36. K.A. Padgett, C. Selmi, T.P.Kenny, P.S. Leung, D.L. Balkwill, A.A. Ansari, R.L. Coppel et al., Phylogenetic and immunological definition of four lipoylated proteins from Novosphingobium aromaticivorans, implications for primary biliary cirrhosis, J Autoimmun 24 (2005), 209-219. (Pubitemid 40545883)
37. T. Shi, J.K. Fredrickson and D.L. Balkwill, Biodegradation of polycyclic aromatic hydrocarbons by Sphingomonas strains isolated from the terrestrial subsurface, J IndMicrobiol Biotechnol 26 (2001), 283-289. (Pubitemid 32721590)
38. H.R. Walden, J.A. Kirby, S.J. Yeaman, J. Gray, D.E. Jones and J.M. Palmer, Xenobiotic incorporation into pyruvate dehydrogenase complex can occur via the exogenous lipoylation pathway, Hepatology 48 (2008), 1874-1884.
39. A.K. Burroughs, P. Butler, M.J. Sternberg and H. Baum, Molecular mimicry in liver disease, Nature 358 (1992), 377-378.
40. U. Hopf, B. Moller, R. Stemerowicz, H. Lobeck, A. Rodloff, M. Freudenberg et al., Relation between Escherichia coli R (rough)forms in gut, lipid A in liver, and primary biliary cirrhosis, Lancet 2 (1989), 1419-1422. (Pubitemid 20012059)
41. H.Miyakawa, A. Tanaka, C. Selmi, N. Hosoya, N.Mataki, K. Kikuchi et al., Serum reactivity against bacterial pyruvate dehydrogenase: increasing the specificity of anti mitochondrial antibodies for the diagnosis of primary biliary cirrhosis, Clin Dev Immunol 13 (2006), 289-294. (Pubitemid 44950044)
42. A. ParikhPatel, E.B. Gold, H. Worman, K.E. Krivy and M.E. Gershwin, Risk factors for primary biliary cirrhosis in a cohort of patients from the united states, Hepatology 33 (2001), 16-21. (Pubitemid 32016882)
43. P. Butler, J. HamiltonMiller, H. Baum and A.K. Burroughs, Detection of M2 antibodies in patients with recurrent urinary tract infection using an ELISA and purified PBC specific antigens. Evidence for a molecular mimicry mechanism in the pathogenesis of primary biliary cirrhosis?, Biochem Mol Biol Int 35 (1995), 473-485. (Pubitemid 26177820)
44. H. Baum, D.P. Bogdanos and D. Vergani, Antibodies to Clp protease in primary biliary cirrhosis: possible role of a mimicking Tcell epitope, J Hepatol 34 (2001), 785-787. (Pubitemid 32488803)
45. I. Mayo, P. Arizti, A. Pares, J. Oliva, R.A. Doforno, M.R. de Sagarra et al., Antibodies against theCOOHterminal region of E. coli ClpP protease in patients with primary biliary cirrhosis, J Hepatol 33 (2000), 528-536.
46. S. Shimoda, M. Nakamura, H. Shigematsu, H. Tanimoto, T. Gushima, M.E. Gershwin et al., Mimicry peptides of human PDCE2 163-176 peptide, the immunodominant Tcell epitope of primary biliary cirrhosis, Hepatology 31 (2000), 1212-1216. (Pubitemid 30351280)
47. A.S. Abdulkarim, L.M. Petrovic, W.R. Kim, P. Angulo, R.V. Lloyd andK.D. Lindor, Primary biliary cirrhosis: an infectious disease caused by Chlamydia pneumoniae? J Hepatol 40 (2004), 380-384. (Pubitemid 38230836)
48. P.S. Leung, O. Park, S. Matsumura, A.A. Ansari, R.L. Coppel and M.E. Gershwin, Is there a relation between Chlamydia infection and primary biliary cirrhosis? Clin Dev Immunol 10 (2003), 227-233. (Pubitemid 38089415)
49. J. O-Donohue, B. McFarlane, A. Bomford, M. Yates and R. Williams, Antibodies to atypical mycobacteria in primary biliary cirrhosis, J Hepatol 21 (1994), 887-889. (Pubitemid 24374160)
50. L. Vilagut, J. Vila, O. Vinas, A. Pares, A. Gines,M.T. Jimenez de Anta et al., Crossreactivity of antiMycobacterium gordonae antibodies with the major mitochondrial autoantigens in primary biliary cirrhosis, J Hepatol 21 (1994), 673-677. (Pubitemid 24324046)
51. S. AbuMouch, C. Selmi, G.D. Benson, T.P. Kenny, P. Invernizzi, M. Zuin et al., Geographic clusters of primary biliary cirrhosis, Clin Dev Immunol 10 (2003), 127-131. (Pubitemid 38089403)
52. P. Invernizzi, Geoepidemiology of autoimmune liver diseases, J Autoimmun 34 (2010), 300-306.
53. A.T. Borchers, S.M. Naguwa, Y. Shoenfeld and M.E. Gershwin, The geoepidemiology of systemic lupus erythematosus, Autoimmun Rev 9 (2010), 277-287.
54. Y. Shapira, N. AgmonLevin and Y. Shoenfeld, Defining and analyzing geoepidemiology and human autoimmunity, J Autoimmun 34 (2010), 168-177.
55. P. Youinou, J.O. Pers, M.E. Gershwin and Y. Shoenfeld, Geoepidemiology and autoimmunity, J Autoimmun 34 (2010), 163-167.
56. B. Gilburd, L. Ziporen, D. Zharhary, M. Blank, N. Zurgil, M.A. Scheinberg et al., Antimitochondrial (pyruvate dehydrogenase) antibodies in leprosy, J Clin Immunol 14 (1994), 14-19. (Pubitemid 24071696)
57. D.P. Bogdanos, H. Baum, M. Okamoto, P. Montalto, U.C. Sharma, E.I. Rigopoulou et al., Primary biliary cirrhosis is characterized by IgG3 antibodies crossreactive with the major mitochondrial autoepitope and its Lactobacillus mimic, Hepatology 42 (2005), 458-465. (Pubitemid 41061099)
58. S.K. Singh, R. Grimaud, J.R. Hoskins, S. Wickner and M.R. Maurizi, Unfolding and internalization of proteins by the ATPdependent proteases ClpXP and ClpAP, Proc Natl Acad Sci USA 97 (2000), 8898-8903. (Pubitemid 30626645)
59. A. Saebo and J. Lassen, Acute and chronic liver disease associated with Yersinia enterocolitica infection: a Norwegian 10year followup study of 458 hospitalized patients, J Intern Med 231 (1992), 531-535.
60. D.P. Bogdanos, H. Baum, U.C. Sharma, A. Grasso, Y. Ma, A.K. Burroughs et al., Antibodies against homologous microbial caseinolytic proteases P characterise primary biliary cirrhosis, J Hepatol 36 (2002), 14-21. (Pubitemid 34234011)
61. G.N. DeLorenze, K.L. Munger, E.T. Lennette, N. Orentreich, J.H. Vogelman and A. Ascherio, EpsteinBarr virus and multiple sclerosis: evidence of association from a prospective study with longterm followup, Arch Neurol 63 (2006), 839-844. (Pubitemid 43882291)
62. E. Toussirot and J. Roudier, EpsteinBarr virus in autoimmune diseases, Best Pract Res Clin Rheumatol 22 (2008), 883-896.
63. O. Barzilai, Y. Sherer, M. Ram, D. Izhaky, J.M. Anaya and Y. Shoenfeld, EpsteinBarr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report, Ann N Y Acad Sci 1108 (2007), 567-577. (Pubitemid 47528770)
64. S.A. Morshed, M. Nishioka, I. Saito, K. Komivama and I. Moro, Increased expression of EpsteinBarr virus in primary biliary cirrhosis patients, Gastroenterol Jpn 27 (1992), 751-758. (Pubitemid 23066541)
65. A.L.Mason, L. Xu, L. Guo, S. Munoz, J.B. Jaspan, M. BryerAsh et al., Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders, Lancet 351 (1998), 1620-1624. (Pubitemid 28252178)
66. L. Xu, M. Sakalian, Z. Shen, G. Loss, J. Neuberger, A.Mason et al., Cloning the human betaretrovirus proviral genome from patients with primary biliary cirrhosis, Hepatology 39 (2004), 151-156. (Pubitemid 38461477)
67. T. Sadamoto, R. Joplin, A. Keogh, A. Mason, W. Carman and J. Neuberger, Expression of pyruvatedehydrogenase complex PDCE2 on biliary epithelial cells induced by lymph nodes fromprimary biliary cirrhosis, Lancet 352 (1998), 1595-1596. (Pubitemid 28515247)
68. A. Mason, L. Xu, Z. Shen, B. Fodera, R. Joplin, J. Neuberger et al., Patients with primary biliary cirrhosis make antiviral and antimitochondrial antibodies to mouse mammary tumor virus, Gastroenterology 127 (2004), 1863-1864.
69. L. Xu, Z. Shen, L. Guo, B. Fodera, A. Keogh, R. Joplin et al., Does a betaretrovius infection trigger primary biliary cirrhosis? Proc Natl Acad Sci USA 100 (2003), 8454-8459. (Pubitemid 36842566)
70. C. Selmi, S.R. Ross, A.A. Ansari, P. Ivernizzi, M. Podda, R.L. Coppel et al., Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis, Gastroenterology 127 (2004), 493-501. (Pubitemid 39091898)
71. M. Durazzo, F. Rosina, A. Premoli, E. Morello, S. Fagoonee, R. Innarella et al., Lack of association between seroprevalence of Helicobacter pylori infection and primary biliary cirrhosis, World J Gastroenterol 10 (2004), 3179-3181. (Pubitemid 39419883)
72. S.Y. Boomkens, S. de Rave, R.G. Pot, H.F. Egberink, L.C. Penning, J. Rothuizen et al., The role of Helicobacter spp. In the pathogenesis of primary biliary cirrhosis and primary sclerosing cholangitis, FEMS Immunol Med Microbiol 44 (2005), 221-225. (Pubitemid 41373380)
73. B.D. Juran, E.J. Atkinson, J.J. Larson, E.M. Schlicht and K.N. Lazaridis, Common genetic variation and haplotypes of the anion exchanger SLC4A2 in primary biliary cirrhosis, Am J Gastroenterol 104 (2009), 1406-1411.
74. C. Selmi and M.E. Gershwin, The role of environmental factors in primary biliary cirrhosis, Trends Immunol 30 (2009), 415-420.
75. M.I. Pince, S.J. Ducker and O.F. James, Casecontrol studies of risk factors for primary biliary cirrhosis in two United Kingdom populations, Gut 59 (2010), 508-512.
76. R. Rieger and M.E. Gershwin, The X and why of xenobiotics in primary biliary cirrhosis, J Autoimmun 28 (2007), 76-84. (Pubitemid 46680497)
77. R.J. McNally, S. Ducker and O.F. James, Are transient environmental agents involved in the cause of primary biliary cirrhosis? Evidence from spacetime clustering analysis, Hepatology 50 (2009), 1169-1174.